about
P361
Cystic fibrosis transmembrane conductance regulatorAryl-hydrocarbon receptorAryl hydrocarbon receptorG protein subunit alpha i1Adenylate cyclase 6Adenylate cyclase 3Adenylate cyclase 5Adenylate cyclase 8Adenylate cyclase 2Adenylate cyclase 1Ephrin A5Histone deacetylase 8Aldo-keto reductase family 1, member C18Adenylate cyclase 1Adenylate cyclase 5Adenylate cyclase 8Adenylate cyclase 6Adenylate cyclase type 2Adenylate cyclase 3Ephrin A5Ferredoxin 1Guanine nucleotide binding protein (G protein), alpha inhibiting 1Eph receptor A5Heterogeneous nuclear ribonucleoprotein KHistone deacetylase 8Prostaglandin E2 receptor EP3 subtypeAdenylate cyclase 6Adenylate cyclase 3CF transmembrane conductance regulatorAldo-keto reductase family 1, member C3Adenylate cyclase 2Glutamate ionotropic receptor NMDA type subunit 2BProstaglandin E receptor 3Histone deacetylase 8Adenylate cyclase 5G protein subunit alpha i1Heterogeneous nuclear ribonucleoprotein KCystic fibrosis transmembrane conductance regulatorFerredoxin 1CF transmembrane conductance regulator
P682
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymiaIncreased enzyme activity and beta-adrenergic mediated vasodilation in subjects expressing a single-nucleotide variant of human adenylyl cyclase 6A Ser/Thr cluster within the C-terminal domain of the rat prostaglandin receptor EP3alpha is essential for agonist-induced phosphorylation, desensitization and internalizationCFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epitheliumDynamic control of cystic fibrosis transmembrane conductance regulator Cl(-)/HCO3(-) selectivity by external Cl(-)
P921
Q14864718-FE9E9E3B-8C52-4EB4-97D3-F6AC56C45511Q14916326-5C616BC5-E56A-4678-AA18-E2E716C1317AQ155750-3445486B-D226-4B83-BF7D-5EB5B6419871Q21106184-09EEB038-3120-4462-B502-541B5ACC2CC4Q21106184-24EEAB08-64E8-441D-8534-12A80EBCE466Q21111191-A8B3CEC9-1E1A-499A-BA86-F616B5D988AEQ21111192-930E708C-8FDA-4770-8E97-F25A0BA74008Q21111195-B63323E3-8BFB-4FCF-B69C-79374B17718EQ21111198-3D119313-CE45-4AAD-82C7-96D0B6E1BBA8Q21111201-8C2BF533-C43E-443C-BA79-E32E04D688BBQ21111202-8E494F10-2144-465C-97BF-5CF8FD3C794EQ21156348-9C19D61A-2525-45FA-B7A3-A0DAD6096533Q21173406-E8578AFF-E43C-4C90-BC6F-3E36F4E43592Q21421968-E338556A-2F43-42C1-BC9A-E1E51C4285DAQ21495333-295FF5CD-D04B-4FE4-867D-DE5D03A1E6C3Q21495339-F7B211BF-C514-4C5B-A9B8-D6FDE608C7ACQ21495340-D5ED453F-2171-4D2C-AF98-D6AF09844929Q21495340-EC4026C1-49A0-4707-8FF7-F64F3E008764Q21495342-E17DBC21-4135-45C4-9AB8-2768CA07B9E1Q21495356-BBB236AC-E28D-41B9-8A27-8E5B1851E44FQ21495363-39A07F67-D351-432C-AAE4-A0383585193CQ21495542-574FEB83-8874-45C9-B962-382259275E9AQ21496853-122D3977-EA6C-4BFB-8A83-E73E88C3DF7FQ21498531-0F7B5C26-B9C5-494C-8BB9-8A65C71A1849Q21979769-BC0CFA75-7833-4C05-A59B-2E92F32AB40BQ21984489-DDE3379C-5933-46B0-BA83-789D9ACE535AQ21984938-8854B950-6427-41B3-BAC8-8FBBD25E737DQ21987842-DCA8E235-AFFB-4661-92F0-36267252E4B1Q28555964-E906EEE1-3A50-4E09-A071-95C6F1A8C7C1Q28556735-163F33A1-D0CB-4F44-8D17-80B825A58F5DQ28557415-61F38D49-BAEF-4877-8415-43893E50E91FQ28557657-6AAC0589-5ED1-4915-9161-244C3C2049DFQ28557953-E8B0B317-6802-4012-9E41-6F7DC547987FQ28559549-C3857BC0-42F3-477A-8BD9-06D45A184B86Q28559745-D76A07FA-D07F-44CC-A522-30874AF1D3C6Q28560117-7F56E796-E30A-4808-BCC2-7E9E765C5203Q28561001-E2028E46-2B5D-4A54-A631-25D09B0A2D1FQ28561185-CF161A56-2A32-427F-85A1-60B64D8D03D3Q28562603-F326C8E8-5909-4D3F-98B6-8B2EA49ED021Q420470-9BB4872E-61F1-419F-B8A5-B6E2F796D2C2
P682
description
Any process that results in a ...... esult of a forskolin stimulus.
@en
biologisch proces
@nl
name
cellular response to forskolin
@en
type
label
cellular response to forskolin
@en
prefLabel
cellular response to forskolin
@en
P279
P279
P2888
P527
P686
GO:1904322